Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000932440-06-000539
Filing Date
2006-11-29
Accepted
2006-11-29 16:50:03
Documents
3

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sch13g_1149910.txt SC 13G 17640
2 EXHIBIT 99.1 exhibit99-1_1149929.txt EX-99 2100
3 EXHIBIT 24.1 exhibit24-1_1149928.txt EX-24 3467
  Complete submission text file 0000932440-06-000539.txt   25253
Mailing Address 1220 GLENMORE DRIVE APOPKA FL 32712
Business Address 1220 GLENMORE DRIVE APOPKA FL 32712 407-880-2213
SHEFFIELD PHARMACEUTICALS INC (Subject) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-50777 | Film No.: 061245894
SIC: 6770 Blank Checks

Mailing Address 430 PARK AVENUE 12TH FLOOR NEW YORK NY 10022
Business Address 430 PARK AVENUE 12TH FLOOR NEW YORK NY 10022 212-624-2567
Ridgeback Capital Investments Ltd. (Filed by) CIK: 0001358916 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G